t5-small-finetuned-pubmed

Try a prompt

• Patient A, a 67-year-old male with a history of hypertension and obesity, received his first dose of the Pfizer COVID-19 vaccine on January 5th, 2022. He reported no adverse reactions following the vaccine and was discharged home. However, two days later, he presented to the emergency department with complaints of chest pain, shortness of breath, and cough. He was found to have an elevated troponin level and was diagnosed with an acute myocardial infarction (AMI) as his primary diagnosis. The cause of death was determined to be due to complications of the AMI, which led to cardiogenic shock and subsequent multi-organ failure. Secondary diagnoses included acute respiratory distress syndrome (ARDS) and acute renal failure. Symptoms included chest pain, shortness of breath, cough, and hypotension. Rule out diagnoses included COVID-19 infection and pulmonary embolism. The patient had a medical history of hypertension, obesity, and hyperlipidemia. There was no significant family history. The patient was treated with thrombolytic therapy and mechanical ventilation but unfortunately, he succumbed to his illness and passed away on January 13th, 2022. The Pfizer COVID-19 vaccine was noted as part of his medical history. The case was reported to the Vaccine Adverse Event Reporting System (VAERS) for further investigation.Copy